Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Cyclopure
Skokie, Illinois, United States
- Ownership
- Private
- Development stage
- Other
01
Overview
Cyclopure’s DEXSORB platform, based on renewable β-cyclodextrin polymers, is commercially available and has demonstrated high efficacy in removing PFAS, including PFOA and PFOS, from water at trace levels, with regulatory approval for use in multiple states and broad municipal and residential deployment[2][5].
- Industry
- Non-Drug Biotech
02
Partnerships
National Science FoundationNational Institute of Environmental Health Sciences (NIEHS)Department of Defense (site-level collaboration for remediation)[2]
Beyond the preview
Go deeper on Cyclopure.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Cyclopure.